Epilepsy, cognition, and neuropsychiatry (Epilepsy, Brain, and Mind, part 2)

[1]  J. Ballenger.  Targeting the Glutamatergic System to Treat Major Depressive Disorder: Rationale and Progress to Date , 2013 .

[2]  P. Drew,et al.  Catastrophising and normalising in patient's accounts of their seizure experiences , 2012, Seizure.

[3]  A. Kaye,et al.  Psychiatric history does not predict seizure outcome following temporal lobectomy for mesial temporal sclerosis , 2012, Epilepsia.

[4]  J. M. Lina,et al.  Recording and analysis techniques for high-frequency oscillations , 2012, Progress in Neurobiology.

[5]  W. Hauser,et al.  Epilepsy, suicidality, and psychiatric disorders: A bidirectional association , 2012, Annals of neurology.

[6]  P. Ryvlin,et al.  5-HT1A receptor binding changes in patients with major depressive disorder before and after antidepressant treatment: A pilot [18F]MPPF positron emission tomography study , 2012, Psychiatry Research: Neuroimaging.

[7]  T. Tomson,et al.  Host factors affecting antiepileptic drug delivery-pharmacokinetic variability. , 2012, Advanced drug delivery reviews.

[8]  M. LeVanQuyen.  This special issue of Progress in Neurobiology is dedicated to the meeting held at the Montreal Neurological Institute, Canada. Introduction. , 2012 .

[9]  J D Norrie,et al.  Patterns of treatment response in newly diagnosed epilepsy , 2012, Neurology.

[10]  P. Patsalos,et al.  Methodologies used to identify and characterize interactions among antiepileptic drugs , 2012, Expert review of clinical pharmacology.

[11]  B. Yee,et al.  Role of gabapentin enacarbil XR in restless legs syndrome , 2012, Therapeutics and clinical risk management.

[12]  M. Coory,et al.  A systematic review of two outcomes in autism spectrum disorder – epilepsy and mortality , 2012, Developmental medicine and child neurology.

[13]  Asla Pitkänen,et al.  Identification of new epilepsy treatments: Issues in preclinical methodology , 2012, Epilepsia.

[14]  J. Hirvonen,et al.  Increased In Vivo Expression of an Inflammatory Marker in Temporal Lobe Epilepsy , 2012, The Journal of Nuclear Medicine.

[15]  Nanxin Li,et al.  Signaling pathways underlying the rapid antidepressant actions of ketamine , 2012, Neuropharmacology.

[16]  C. Zarate,et al.  Targeting the Glutamatergic System to Treat Major Depressive Disorder , 2012, Drugs.

[17]  Philippe Kahane,et al.  Reading the mind's eye: Online detection of visuo-spatial working memory and visual imagery in the inferior temporal lobe , 2012, NeuroImage.

[18]  S. Johannessen,et al.  Safety aspects of antiepileptic drugs—focus on pharmacovigilance , 2012, Pharmacoepidemiology and drug safety.

[19]  P. Ryvlin,et al.  5-HT1A receptor binding changes in patients with major depressive disorder before and after antidepressant treatment: A pilot ( 18 F)MPPF positron emission , 2012 .

[20]  Peter McGuffin,et al.  Hippocampal atrophy in first episode depression: a meta-analysis of magnetic resonance imaging studies. , 2011, Journal of affective disorders.

[21]  J. Trollor,et al.  International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy , 2011, Epilepsia.

[22]  Juan R. Vidal,et al.  Transient Suppression of Broadband Gamma Power in the Default-Mode Network Is Correlated with Task Complexity and Subject Performance , 2011, The Journal of Neuroscience.

[23]  D. Hesdorffer,et al.  Suicidal behavior and antiepileptic drugs in epilepsy : analysis of the emerging evidence , 2011 .

[24]  Willem A. Nolen,et al.  Inhibit yourself and understand the other: Neural basis of distinct processes underlying Theory of Mind , 2011, NeuroImage.

[25]  L. Wise.  Risks and benefits of (pharmaco)epidemiology , 2011, Therapeutic advances in drug safety.

[26]  F. Benuzzi,et al.  Recognition of emotions from faces and voices in medial temporal lobe epilepsy , 2011, Epilepsy & Behavior.

[27]  R. Tuchman,et al.  Risk and Correlates of Autism Spectrum Disorder in Children With Epilepsy: A Community-Based Study , 2011, Journal of child neurology.

[28]  Emmanuel Maby,et al.  Inferring hand movement kinematics from MEG, EEG and intracranial EEG: From brain-machine interfaces to motor rehabilitation Décoder la cinématique d'un mouvement de la main à partir d'enregistrements MEG et EEG: des interfaces cerveau-machine à la réhabilitation motrice , 2011 .

[29]  M. Thase,et al.  The clinical management of bipolar disorder: a review of evidence-based guidelines. , 2011, The primary care companion for CNS disorders.

[30]  Eva Meisenzahl,et al.  Structural MRI correlates for vulnerability and resilience to major depressive disorder. , 2011, Journal of psychiatry & neuroscience : JPN.

[31]  M. Cuccaro,et al.  Autism spectrum disorders and epilepsy: Moving towards a comprehensive approach to treatment , 2010, Brain and Development.

[32]  M. Cuccaro,et al.  Autism and epilepsy: Historical perspective , 2010, Brain and Development.

[33]  Nicholas D. Walsh,et al.  Subregional Hippocampal Deformations in Major Depressive Disorder , 2022 .

[34]  J. Britton,et al.  Drug, Healthcare and Patient Safety Dovepress Antiepileptic Drugs and Suicidality , 2022 .

[35]  C. Szoeke,et al.  Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients , 2010, Neurology.

[36]  Josemir W Sander,et al.  Assessing suicidal risk with antiepileptic drugs , 2010, Neuropsychiatric disease and treatment.

[37]  R. Duncan.  Faculty Opinions recommendation of Quantifying the response to antiepileptic drugs: effect of past treatment history. , 2010 .

[38]  Gary W. Mathern,et al.  Erratum: Definition of drug resistant epilepsy. Consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies (Epilepsia (2010) 51 (1069-77)) , 2010 .

[39]  François Mauguière,et al.  Brain responses to success and failure: Direct recordings from human cerebral cortex , 2010, Human brain mapping.

[40]  H. Potschka.  Modulating P‐glycoprotein regulation: Future perspectives for pharmacoresistant epilepsies? , 2010, Epilepsia.

[41]  P. G. Larsson,et al.  Psychiatric comorbidity in patients with epilepsy: a population-based study , 2010, European Journal of Clinical Pharmacology.

[42]  R. Parsey,et al.  Higher Serotonin 1A Binding in a Second Major Depression Cohort: Modeling and Reference Region Considerations , 2010, Biological Psychiatry.

[43]  J. Rejas,et al.  Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: Findings from a cost-consequences analysis in a nested case-control study. , 2010, Clinical therapeutics.

[44]  B. Bourgeois,et al.  The Epilepsy Prescriber's Guide to Antiepileptic Drugs , 2010 .

[45]  C. V. van Donselaar,et al.  Course and outcome of childhood epilepsy: A 15‐year follow‐up of the Dutch Study of Epilepsy in Childhood , 2010, Epilepsia.

[46]  P. Weeke,et al.  Antiepileptic drugs and risk of suicide: a nationwide study , 2010, Pharmacoepidemiology and drug safety.

[47]  J. Avorn,et al.  Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. , 2010, Journal of the American Medical Association (JAMA).

[48]  Philippe Kahane,et al.  Exploring the electrophysiological correlates of the default ‐ mode network with intracerebral EEG , 2022 .

[49]  Thomas Wisniewski,et al.  The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes , 2010, Acta Neuropathologica.

[50]  C. Gillberg,et al.  Mortality in Autism: A Prospective Longitudinal Community-Based Study , 2010, Journal of autism and developmental disorders.

[51]  P. Gebicke-haerter,et al.  Reduced expression of glutamate transporters vGluT1, EAAT2 and EAAT4 in learned helpless rats, an animal model of depression , 2010, Neuropharmacology.

[52]  P. Manganotti,et al.  Effects of intravenous antidepressant drugs on the excitability of human motor cortex: a study with paired magnetic stimulation on depressed patients , 2010, Brain Stimulation.

[53]  J. Cramer,et al.  Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VA hospital system , 2010, BMC medicine.

[54]  P. Patsalos,et al.  Drug interactions involving the new second- and third-generation antiepileptic drugs , 2010, Expert review of neurotherapeutics.

[55]  C. Andrade,et al.  Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications , 2010, Mens Sana Monographs.

[56]  H. Möller,et al.  The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression , 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[57]  G. Mathern,et al.  Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies , 2009, Epilepsia.

[58]  B. Bourgeois,et al.  Comprar The Epilepsy Prescriber's Guide to Antiepileptic Drugs | Philip N. Patsalos | 9780521687164 | Cambridge University Press , 2010 .

[59]  R. Boellaard,et al.  Reduced parahippocampal and lateral temporal GABAA-[11C]flumazenil binding in major depression: preliminary results , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[60]  Andreas Schulze-Bonhage,et al.  Preoperative depressive symptoms predict postoperative seizure outcome in temporal and frontal lobe epilepsy , 2009, Epilepsy & Behavior.

[61]  P. G. Larsson,et al.  Antiepileptic drugs in epilepsy and other disorders—A population-based study of prescriptions , 2009, Epilepsy Research.

[62]  P. Skolnick,et al.  Glutamate-based antidepressants: 20 years on. , 2009, Trends in pharmacological sciences.

[63]  W. Oertel,et al.  Etiology and site of temporal lobe epilepsy influence postictal cytokine release , 2009, Epilepsy Research.

[64]  Chiara M. Monzoni,et al.  Using interactional and linguistic analysis to distinguish between epileptic and psychogenic nonepileptic seizures: A prospective, blinded multirater study , 2009, Epilepsy & Behavior.

[65]  Josemir W Sander,et al.  Suicide in people with epilepsy: How great is the risk? , 2009, Epilepsia.

[66]  G. Cantalupo,et al.  Facial emotion recognition impairment in chronic temporal lobe epilepsy , 2009, Epilepsia.

[67]  Philippe Kahane,et al.  Task‐related gamma‐band dynamics from an intracerebral perspective: Review and implications for surface EEG and MEG , 2009, Human brain mapping.

[68]  M. Reuber,et al.  Seizure metaphors differ in patients’ accounts of epileptic and psychogenic nonepileptic seizures , 2009, Epilepsia.

[69]  D. Hesdorffer,et al.  The FDA alert on suicidality and antiepileptic drugs: Fire or false alarm? , 2009, Epilepsia.

[70]  Dennis S. Charney,et al.  Amino Acid Neurotransmitters Assessed by Proton Magnetic Resonance Spectroscopy: Relationship to Treatment Resistance in Major Depressive Disorder , 2009, Biological Psychiatry.

[71]  Josemir W Sander,et al.  The role of titration schedule of topiramate for the development of depression in patients with epilepsy , 2009, Epilepsia.

[72]  C. Zarate,et al.  Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders. , 2009, Current pharmaceutical design.

[73]  Karim Jerbi,et al.  Simultaneous MEG and intracranial EEG recordings during attentive reading , 2009, NeuroImage.

[74]  C. Gillberg,et al.  Autism spectrum disorder in children with and without epilepsy: impact on social functioning and communication , 2009, Acta paediatrica.

[75]  J. Wuu,et al.  A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy , 2009, Neurology.

[76]  Philippe Kahane,et al.  Saccade Related Gamma-Band Activity in Intracerebral EEG: Dissociating Neural from Ocular Muscle Activity , 2009, Brain Topography.

[77]  M. Reuber,et al.  Making the diagnosis in patients with blackouts: it’s all in the history , 2009, Practical Neurology.

[78]  Philippe Kahane,et al.  Watching brain TV and playing brain ball exploring novel BCI strategies using real-time analysis of human intracranial data. , 2009, International review of neurobiology.

[79]  C. J. Landmark,et al.  Antiepileptic Drugs in Non-Epilepsy Disorders , 2012 .

[80]  Nicole Fiori,et al.  Impaired facial expression recognition in children with temporal lobe epilepsy: Impact of early seizure onset on fear recognition , 2008, Neuropsychologia.

[81]  E. Saemundsen,et al.  Risk of autism spectrum disorders after infantile spasms: A population‐based study nested in a cohort with seizures in the first year of life , 2008, Epilepsia.

[82]  M. Baulac,et al.  Epilepsy in Autism is Associated with Intellectual Disability and Gender: Evidence from a Meta-Analysis , 2008, Biological Psychiatry.

[83]  M. Mula.  Anticonvulsants - antidepressants pharmacokinetic drug interactions: the role of the CYP450 system in psychopharmacology. , 2008, Current drug metabolism.

[84]  P. Siddarth,et al.  Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine. , 2008, Brain : a journal of neurology.

[85]  Bruce Hermann,et al.  Consensus statement: The evaluation and treatment of people with epilepsy and affective disorders , 2008, Epilepsy & Behavior.

[86]  B. Bourgeois,et al.  Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies , 2008, Epilepsia.

[87]  P. Keck,et al.  Antiepileptic drugs to treat psychiatric disorders , 2008 .

[88]  Robert T. Knight,et al.  Five-dimensional neuroimaging: Localization of the time–frequency dynamics of cortical activity , 2008, NeuroImage.

[89]  M. Leboyer,et al.  Inter-hemispheric asymmetry of motor corticospinal excitability in major depression studied by transcranial magnetic stimulation. , 2008, Journal of psychiatric research.

[90]  O Bertrand,et al.  Silence is golden: transient neural deactivation in the prefrontal cortex during attentive reading. , 2008, Cerebral cortex.

[91]  Josemir W Sander,et al.  The pharmacological treatment of depression in adults with epilepsy. , 2008, Expert opinion on pharmacotherapy.

[92]  C. Johannessen Landmark,et al.  Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy. , 2008, CNS drugs.

[93]  W. LaFrance,et al.  Psychiatric comorbidities in epilepsy. , 2008, International review of neurobiology.

[94]  Scott B Patten,et al.  Psychiatric Comorbidity in Epilepsy: A Population‐Based Analysis , 2007, Epilepsia.

[95]  Josemir W Sander,et al.  Are Psychiatric Adverse Events of Antiepileptic Drugs a Unique Entity? A Study on Topiramate and Levetiracetam , 2007, Epilepsia.

[96]  O. Bertrand,et al.  Relationship between task‐related gamma oscillations and BOLD signal: New insights from combined fMRI and intracranial EEG , 2007, Human brain mapping.

[97]  Benoit Cottereau,et al.  Multiresolution imaging of MEG cortical sources using an explicit piecewise model , 2007, NeuroImage.

[98]  Philippe Kahane,et al.  A Blueprint for Real-Time Functional Mapping via Human Intracranial Recordings , 2007, PloS one.

[99]  Masanori Ichise,et al.  Elevated Serotonin Transporter Binding in Major Depressive Disorder Assessed Using Positron Emission Tomography and [11C]DASB; Comparison with Bipolar Disorder , 2007, Biological Psychiatry.

[100]  H. Hara.  Autism and epilepsy: A retrospective follow-up study , 2007, Brain and Development.

[101]  Russell L. Kolts,et al.  Seizure Incidence in Psychopharmacological Clinical Trials: An Analysis of Food and Drug Administration (FDA) Summary Basis of Approval Reports , 2007, Biological Psychiatry.

[102]  Esben Agerbo,et al.  Epilepsy and risk of suicide: a population-based case–control study , 2007, The Lancet Neurology.

[103]  Josemir W Sander,et al.  Suicidal ideation in epilepsy and levetiracetam therapy , 2007, Epilepsy & Behavior.

[104]  S. Rees,et al.  The acceleration of amygdala kindling epileptogenesis by chronic low-dose corticosterone involves both mineralocorticoid and glucocorticoid receptors , 2007, Psychoneuroendocrinology.

[105]  John Norrie,et al.  Predictors of pharmacoresistant epilepsy , 2007, Epilepsy Research.

[106]  D. Kupfer,et al.  Measurement of 5‐HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY‐100635 , 2007, Synapse.

[107]  P. Bech.  Dose-response Relationship of Pregabalin in Patients with Generalized Anxiety Disorder. A Pooled Analysis of Four Placebo-controlled Trials , 2007, Pharmacopsychiatry.

[108]  I. Olson,et al.  The Enigmatic temporal pole: a review of findings on social and emotional processing. , 2007, Brain : a journal of neurology.

[109]  D. Yurgelun-Todd,et al.  The right-hemisphere and valence hypotheses: could they both be right (and sometimes left)? , 2007, Social cognitive and affective neuroscience.

[110]  M. Mula,et al.  The Role of Anticonvulsant Drugs in Anxiety Disorders: A Critical Review of the Evidence , 2007, Journal of clinical psychopharmacology.

[111]  Hans-Jürgen Möller,et al.  Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. , 2007, Archives of general psychiatry.

[112]  T. Fakhoury,et al.  Lamotrigine in patients with epilepsy and comorbid depressive symptoms , 2007, Epilepsy & Behavior.

[113]  A. Hammer,et al.  Effect of lamotrigine on depressive symptoms in adult patients with epilepsy , 2007, Epilepsy & Behavior.

[114]  Josemir W Sander,et al.  Negative Effects of Antiepileptic Drugs on Mood in Patients with Epilepsy , 2007, Drug safety.

[115]  H. Jokeit,et al.  Mesial Temporal Lobe Epilepsy Impairs Advanced Social Cognition , 2006, Epilepsia.

[116]  A. Cavanna,et al.  Psychopharmacology of topiramate: from epilepsy to bipolar disorder , 2006, Neuropsychiatric disease and treatment.

[117]  J. Hirsch,et al.  Facial Emotion Recognition after Curative Nondominant Temporal Lobectomy in Patients with Mesial Temporal Sclerosis , 2006, Epilepsia.

[118]  Michael A. Rogawski,et al.  Diverse mechanisms of antiepileptic drugs in the development pipeline , 2006, Epilepsy Research.

[119]  M. Brodie.  Antiepileptic drug interactions: a clinical guide , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[120]  Sarah H. Lisanby,et al.  Evidence for Impaired Cortical Inhibition in Patients with Unipolar Major Depression , 2006, Biological Psychiatry.

[121]  M. Brodie,et al.  Diagnosing refractory epilepsy: response to sequential treatment schedules , 2006, European journal of neurology.

[122]  Dieter Schmidt,et al.  Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. , 2006, Brain : a journal of neurology.

[123]  Olafur Kjartansson,et al.  Depression and suicide attempt as risk factors for incident unprovoked seizures , 2006, Annals of neurology.

[124]  Rebecca Elliott,et al.  Neuronal correlates of theory of mind and empathy: A functional magnetic resonance imaging study in a nonverbal task , 2006, NeuroImage.

[125]  N. Crone,et al.  High-frequency gamma oscillations and human brain mapping with electrocorticography. , 2006, Progress in brain research.

[126]  O. Devinsky,et al.  Psychotropic Effects of Antiepileptic Drugs , 2005, Epilepsy currents.

[127]  I. Fried,et al.  Coupling Between Neuronal Firing, Field Potentials, and fMRI in Human Auditory Cortex , 2005, Science.

[128]  Neeraj Gilhotra,et al.  Safety monitoring of medicinal products , 2005 .

[129]  R. Andersen,et al.  Selecting the signals for a brain–machine interface , 2004, Current Opinion in Neurobiology.

[130]  M. Trimble,et al.  Use of psychotropic drugs in patients with epilepsy: interactions and seizure risk , 2004, Expert review of neurotherapeutics.

[131]  J. Detre,et al.  Functional MRI predicts post-surgical memory following temporal lobectomy. , 2004, Brain : a journal of neurology.

[132]  S. Trottier,et al.  Glyceraldehyde-3-Phosphate Dehydrogenase Is a GABAA Receptor Kinase Linking Glycolysis to Neuronal Inhibition , 2004, The Journal of Neuroscience.

[133]  A. David,et al.  The impact of early and late damage to the human amygdala on 'theory of mind' reasoning. , 2004, Brain : a journal of neurology.

[134]  W. Löscher,et al.  The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions , 2004, Nature Medicine.

[135]  Pedro Rosa-Neto,et al.  Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression. , 2004, Archives of general psychiatry.

[136]  G. Perugi,et al.  Antiepileptic drugs: indications other than epilepsy. , 2004, Epileptic disorders : international epilepsy journal with videotape.

[137]  Y. Michotte,et al.  Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D2 and 5‐HT1A receptors , 2004, Journal of neurochemistry.

[138]  S. Stahl.  Mechanism of action of alpha2delta ligands: voltage sensitive calcium channel (VSCC) modulators. , 2004, The Journal of clinical psychiatry.

[139]  Andrew Calder,et al.  Acquired theory of mind impairments in individuals with bilateral amygdala lesions , 2003, Neuropsychologia.

[140]  H. Mayberg.  Positron emission tomography imaging in depression: a neural systems perspective. , 2003, Neuroimaging clinics of North America.

[141]  Josemir W Sander,et al.  Psychiatric adverse events during levetiracetam therapy , 2003, Neurology.

[142]  A. Kanner.  Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment , 2003, Biological Psychiatry.

[143]  E. Perucca,et al.  Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs , 2003, The Lancet Neurology.

[144]  Josemir W Sander,et al.  Topiramate and Psychiatric Adverse Events in Patients with Epilepsy , 2003, Epilepsia.

[145]  J. Davidson,et al.  Pregabalin in generalized anxiety disorder: a placebo-controlled trial. , 2003, The American journal of psychiatry.

[146]  G. Cantalupo,et al.  Impaired facial emotion recognition in early-onset right mesial temporal lobe epilepsy , 2003, Neurology.

[147]  G. Rondouin,et al.  Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis , 2002, Brain Research.

[148]  M. Mula,et al.  Antiepileptic-Antipsychotic Drug Interactions: A Critical Review of the Evidence , 2002, Clinical neuropharmacology.

[149]  A. Vezzani,et al.  Functional Role of Inflammatory Cytokines and Antiinflammatory Molecules in Seizures and Epileptogenesis , 2002, Epilepsia.

[150]  H. Möller,et al.  World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance Treatment of Major Depressive Disorder and Treatment of Chronic Depressive Disorders and Subthreshold Depressions , 2002, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[151]  P. Patsalos,et al.  The Importance of Drug Interactions in Epilepsy Therapy , 2002, Epilepsia.

[152]  M. Trimble,et al.  Epilepsy, psychosis and clozapine , 2002, Human psychopharmacology.

[153]  B. Schmitz.  Antidepressant Drugs: Indications and Guidelines for Use in Epilepsy , 2002, Epilepsia.

[154]  N. Logothetis,et al.  Neurophysiological investigation of the basis of the fMRI signal , 2001, Nature.

[155]  R. Adolphs,et al.  Emotion recognition from faces and prosody following temporal lobectomy. , 2001, Neuropsychology.

[156]  H. Mayan,et al.  Lithium Intoxication Due to Carbamazepine-Induced Renal Failure , 2001, The Annals of pharmacotherapy.

[157]  E. Yukawa,et al.  Phenytoin intoxication induced by fluvoxamine. , 2001, Therapeutic drug monitoring.

[158]  Á. Pascual-Leone,et al.  Interhemispheric asymmetry of motor cortical excitability in major depression as measured by transcranial magnetic stimulation , 2000, British Journal of Psychiatry.

[159]  E. Angelopoulos,et al.  Acute psychosis and EEG normalisation after vagus nerve stimulation , 2000, Journal of neurology, neurosurgery, and psychiatry.

[160]  Paul Rutecki,et al.  Inter- and intra-subject variability in gabapentin absorption and absolute bioavailability , 2000, Epilepsy Research.

[161]  M. Trimble,et al.  Psychiatric symptoms after therapy with new antiepileptic drugs: Psychopathological and seizure related variables , 2000, Seizure.

[162]  Bernadette Lipinski,et al.  Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study , 2000, Biological Psychiatry.

[163]  John H Krystal,et al.  Antidepressant effects of ketamine in depressed patients , 2000, Biological Psychiatry.

[164]  P. Kwan,et al.  Early identification of refractory epilepsy. , 2000, The New England journal of medicine.

[165]  W. Hauser,et al.  Major depression is a risk factor for seizures in older adults , 2000, Annals of neurology.

[166]  P A Sargent,et al.  Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. , 2000, Archives of general psychiatry.

[167]  A. S. Romero,et al.  Interaction between Trazodone and Carbamazepine , 1999, The Annals of pharmacotherapy.

[168]  D. Kupfer,et al.  Pet imaging of serotonin 1A receptor binding in depression , 1999, Biological Psychiatry.

[169]  Fahmeed Hyder,et al.  Reduced Cortical γ-Aminobutyric Acid Levels in Depressed Patients Determined by Proton Magnetic Resonance Spectroscopy , 1999 .

[170]  O. Devinsky,et al.  Psychiatric adverse events during vigabatrin therapy. , 1999, Neurology.

[171]  A. Vezzani,et al.  Interleukin-1β Immunoreactivity and Microglia Are Enhanced in the Rat Hippocampus by Focal Kainate Application: Functional Evidence for Enhancement of Electrographic Seizures , 1999, The Journal of Neuroscience.

[172]  M. Joëls,et al.  Episodic corticosterone treatment accelerates kindling epileptogenesis and triggers long‐term changes in hippocampal CA1 cells, in the fully kindled state , 1999, The European journal of neuroscience.

[173]  B. Alldredge.  Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations. , 1999, Neurology.

[174]  G F Mason,et al.  Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. , 1999, Archives of general psychiatry.

[175]  Doris Ma Fat,et al.  WHO Library Cataloguing-in-Publication Data , 2001 .

[176]  T. Allison,et al.  Modulation of human extrastriate visual processing by selective attention to colours and words. , 1998, Brain : a journal of neurology.

[177]  E. Settle.  Antidepressant drugs: disturbing and potentially dangerous adverse effects. , 1998, The Journal of clinical psychiatry.

[178]  Trimble,et al.  Forced normalization and alternative psychoses of epilepsy , 1998 .

[179]  G. Edelman,et al.  Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[180]  E. C. Harris,et al.  Suicide as an outcome for mental disorders , 1997, British Journal of Psychiatry.

[181]  P C Bucy,et al.  Preliminary analysis of functions of the temporal lobes in monkeys. 1939. , 1997, The Journal of neuropsychiatry and clinical neurosciences.

[182]  M. Hallett,et al.  Decreased postexercise facilitation of motor evoked potentials in patients with chronic fatigue syndrome or depression , 1996, Neurology.

[183]  S. Stahl,et al.  Book Review: Essential Psychopharmacology: Neuroscientific Basis and Practical Applications, 2nd Edition , 1996 .

[184]  J. Csernansky,et al.  Hippocampal atrophy in recurrent major depression. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[185]  S. Pacia,et al.  Clozapine‐related seizures , 1994, Neurology.

[186]  J. Gotman,et al.  EEG Slow Waves and Memory Performance During the Intracarotid Amobarbital Test , 1994, Epilepsia.

[187]  P. Jalil.  Toxic reaction following the combined administration of fluoxetine and phenytoin: two case reports. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[188]  P. Skolnick,et al.  Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. , 1990, European journal of pharmacology.

[189]  M. Brodie,et al.  Managing seizures in the casualty department. , 1990, BMJ.

[190]  G. Walker,et al.  Chronic subdural strip electrode recordings for difficult epileptic problems , 1988 .

[191]  P. Crumrine,et al.  Phenobarbital treatment and major depressive disorder in children with epilepsy. , 1987, Pediatrics.

[192]  M. Trimble,et al.  Phenomenology of Depression in Epilepsy , 1987, Epilepsia.

[193]  S. Shukla,et al.  Lithium-carbamazepine neurotoxicity and risk factors. , 1984, The American journal of psychiatry.

[194]  Edgar M. Housepian.  Atlas d'anatomie stereotaxique du telencephale. , 1968 .

[195]  M. H. Charlton,et al.  La Stereo-Electroencephalographie dans l' Épilepsie. , 1965 .

[196]  H. Tellenbach.  [EPILEPSY AS A CONVULSIVE DISORDER AND AS A PSYCHOSIS. ON ALTERNATIVE PSYCHOSES OF PARANOID NATURE IN "FORCED NORMALIZATION" (LANDOLT) OF THE ELECTROENCEPHALOGRAM OF EPILEPTICS]. , 1965, Der Nervenarzt.

[197]  H. Landolt.  [Psychic disorders in epilepsy. Clinical and electroencephalographic research]. , 1962, Deutsche medizinische Wochenschrift.

[198]  H. Klüver,et al.  PRELIMINARY ANALYSIS OF FUNCTIONS OF THE TEMPORAL LOBES IN MONKEYS , 1939 .